Floatz logo

Damoctocog Alfa Pegol

Prophylaxis of Bleeding

Bayerprotein_peptidePhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Prophylaxis of Bleeding cohort.

Asset / SponsorPhaseRating
Rivaroxaban
Brigham and Women's Hospital
Phase 4BBB
WARFARIN
Asan Medical Center
Phase 4BBB
Recombinant Human Plasminogen Activator
Hamilton Health Sciences Corporation
Phase 4BB
BLOOD PLASMA
University Health Network, Toronto
Phase 4BB
HUMAN FIBRINOGEN
University Health Network, Toronto
Phase 4BB

View all 24 →

Same molecule, other indications

Damoctocog Alfa Pegol is also rated in:

hemophilia ADormant
BBB
Indicative ·
74 / 100
View asset →
ChildrenDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →